Jama Author Interviews: Covering Research In Medicine, Science, & Clinical Practice. For Physicians, Researchers, & Clinician

Infectious disease and global health expert Carlos del Rio, MD, of Emory University provides an update on the status of the #COVID19 pandemic in summer 2020, prospects for effective treatment and prevention, communicating the ongoing risk to the public, and more. Recorded June 15, 2020. Related Article: Translating Science on COVID-19 to Improve Clinical Care and Support the Public Health Response

Interview with Howard K. Koh, MD, author of Sustainability, Business, and Health Related Article(s): Sustainability, Business, and Health

Interview with William H. Shrank, MD, author of Hospice Carve-In—Aligning Benefits With Patient and Family Needs Related Article: Hospice Carve-In—Aligning Benefits With Patient and Family Needs

COVID-19 critical care update with Maurizio Cecconi, MD, of Humanitas University in Milan, Italy, and JAMA Associate Editor Derek C. Angus, MD, MPH, of the University of Pittsburgh. Recorded June 8, 2020. Related: Management of COVID-19 Respiratory Distress

Interview with Karina W. Davidson, PhD, USPSTF member and coauthor of Screening for Unhealthy Drug Use: US Preventive Services Task Force Recommendation Statement

Interview with Anthony L. Komaroff, MD, author of Can Infections Cause Alzheimer Disease?

Joshua M. Sharfstein, MD, and Christopher Morphew, PhD, of Johns Hopkins University discuss options for opening primary, middle, and high schools in fall 2020. Recorded June 3, 2020. Related Article: The Urgency and Challenge of Opening K-12 Schools in the Fall of 2020

NIAID Director Anthony Fauci, MD, discusses recent developments in the global COVID-19 pandemic with JAMA Editor in Chief Howard Bauchner, MD. Recorded June 2, 2020. Related Article: Anthony Fauci, MD, on COVID-19 Vaccines, Larry Kramer, and Dealing With Criticism

Paul Offit, MD, of the Children's Hospital of Philadelphia, discusses principles and progress to date in COVID-19 vaccine development. Recorded June 1, 2020. Related: Adverse Consequences of Rushing a SARS-CoV-2 Vaccine: Implications for Public Trust

Paul Starr, PhD, Professor of Sociology and Public Affairs at Princeton University, discusses policy options for achieving a new normal in the COVID-19 pandemic. Recorded Thursday, May 28, 2020. Related Article: Using Controlled Trials to Resolve Key Unknowns About Policy During the COVID-19 Pandemic

Interview with Zirui Song, M.D., Ph.D., author of Potential Implications of Lowering the Medicare Eligibility Age to 60

Interview with Humayun J. Chaudhry, DO, author of The USMLE Step 1 Decision: An Opportunity for Medical Education and Training

Interview with Michael Silverstein, MD, MPH, USPSTF member and coauthor of Primary Care–Based Interventions to Prevent Illicit Drug Use in Children, Adolescents, and Young Adults: US Preventive Services Task Force Recommendation Statement

US National Institutes of Health (NIH) Director Francis S. Collins, MD, PhD, discusses the agency's new initiative to collaborate with other agencies and industry to accelerate development and testing of COVID-19 treatments and vaccines. Recorded May 19, 2020. Related: Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): An Unprecedented Partnership for Unprecedented Times

Ezekiel Emanuel, MD, PhD, of the Perelman School of Medicine's Department of Medical Ethics and Health Policy, discusses the use of immunity licensing (immunity passports) as a means to restore public travel, activity, and the economy following the first wave of the COVID-19 pandemic. Recorded May 11, 2020. Related: The Ethics of COVID-19 Immunity-Based Licenses (“Immunity Passports”)

Interview with Paul J. Young, PhD, author of When Should Clinicians Act on Non–Statistically Significant Results From Clinical Trials?

Anne Schuchat, MD, Principal Deputy Director of the Centers for Disease Control and Prevention (CDC), discusses evolution of CDC guidance and latest developments in the COVID-19 pandemic. Recorded Friday May 1, 2020.

Don Berwick, MD, MPP, of the Institute for Healthcare Improvement, discusses choices societies and the medical profession can make to improve health care and reduce inequities as we move out of the acute phase of the coronavirus pandemic.

Interview with Robert D. Truog, MD, MA, author of Understanding Brain Death

The US spends more on health care as a proportion of its GDP than any other nation. Will the COVID-19 pandemic reduce or accelerate that spending? Sherry Glied, PhD, Dean and Professor of Public Service at New York University, explains. Recorded Monday, April 27, 2020. Read the article The Potential Effects of Coronavirus on National Health Expenditures